M-A | Resposta à monoterapia farmacológica aguda para transtornos depressivos maiores em estudos randomizados e placebo-controlados. 5 Ago, 2022 | 16:48h Response to acute monotherapy for major depressive disorder in randomized, placebo controlled trials submitted to the US Food and Drug Administration: individual participant data analysis – The BMJ